SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-15-003634
Filing Date
2015-05-14
Accepted
2015-05-14 07:15:41
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0315_soligenix.htm 10-Q 582947
2 CERTIFICATION f10q0315ex31i_soligenix.htm EX-31.1 12427
3 CERTIFICATION f10q0315ex31ii_soligenix.htm EX-31.2 11887
4 CERTIFICATION f10q0315ex32i_soligenix.htm EX-32.1 4050
5 CERTIFICATION f10q0315ex32ii_soligenix.htm EX-32.2 3283
  Complete submission text file 0001213900-15-003634.txt   3961447

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE sngx-20150331.xml EX-101.INS 515771
7 XBRL SCHEMA FILE sngx-20150331.xsd EX-101.SCH 31385
8 XBRL CALCULATION FILE sngx-20150331_cal.xml EX-101.CAL 27036
9 XBRL DEFINITION FILE sngx-20150331_def.xml EX-101.DEF 91545
10 XBRL LABEL FILE sngx-20150331_lab.xml EX-101.LAB 287252
11 XBRL PRESENTATION FILE sngx-20150331_pre.xml EX-101.PRE 187075
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16929 | Film No.: 15860247
SIC: 2834 Pharmaceutical Preparations